 |
Amonafide L-malate |
|---|---|
| Trade Name | Xanafide |
| Orphan Indication | Acute myeloid leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2006-12-20 00:00:00 |
| Sponsor | Xanthus Pharmaceuticals, Inc.;An Antisoma Group Company, 300 Technology Square;Cambridge, Massachusetts, 02139 |
